Verenium, BP close $98.3M sale of Vercipia

September 3, 2010 |

In Massachusetts, Verenium Corporation (VRNM) , a pioneer in the development and commercialization of high-performance industrial enzyme solutions, today announced the closing of the sale of its cellulosic biofuels business to BP Biofuels North America for $98.3 million, subject to the additional financial terms of the transaction announced on July 15, 2010.

In the transaction, BP acquired the Company’s facilities in Jennings, LA, including the pilot plant and demonstration-scale facility, the San Diego, CA R&D facilities, as well as cellulosic biofuels and cellulosic enzyme technology and related IP.

More on the story.

Print Friendly

Tags: , ,

Category: Producer News

Comments are closed.